Alanine Aminotransferase (ALT) Assay Kit Detection: Principles, Methods, and Clinical Applications

The Alanine Aminotransferase (ALT) assay kit is a widely used clinical chemistry reagent system for quantitative determination of ALT activity in human serum and plasma, serving as a cornerstone of liver function evaluation. Based on the internationally recommended IFCC kinetic UV method, these kits enable rapid, accurate, and reproducible measurement through automated biochemistry analyzers. This article provides a comprehensive technical overview of ALT detection kits, including testing principles, sample requirements, methodologies, clinical applications, and frequently asked questions.

Technical Overview

Alanine aminotransferase (ALT, EC 2.6.1.2), formerly known as serum glutamic pyruvic transaminase (SGPT), is a pyridoxal phosphate-dependent enzyme that catalyzes the reversible transfer of an amino group from L-alanine to alpha-ketoglutarate, yielding pyruvate and L-glutamate. ALT is predominantly localized in the cytoplasm of hepatocytes, with the liver containing the highest concentration of this enzyme in the human body. Consequently, when hepatocellular damage occurs, ALT is rapidly released into the bloodstream, making serum ALT activity one of the most sensitive and specific biomarkers for liver cell injury.

Commercial ALT assay kits are designed for the quantitative determination of ALT catalytic activity concentration in serum or plasma. Most modern kits adopt the method recommended by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), which utilizes a coupled enzymatic reaction with lactate dehydrogenase (LDH) and monitors the oxidation of NADH at 340 nm. The rate of decrease in absorbance is directly proportional to ALT activity in the sample, allowing precise kinetic quantification.

A typical ALT reagent kit consists of two liquid-stable working reagents: Reagent 1 (R1), containing Tris or phosphate buffer, L-alanine, NADH, LDH, and preservatives; and Reagent 2 (R2), containing alpha-ketoglutarate and buffer. Some formulations include pyridoxal phosphate (vitamin B6) as an activator to ensure full expression of ALT apoenzyme activity, in accordance with the revised IFCC reference procedure.

Testing Samples

Serum

Serum is the preferred sample type for ALT determination. Venous blood should be collected into plain tubes or serum separator tubes and allowed to clot completely before centrifugation. Hemolysis should be strictly avoided during collection and handling, as erythrocytes contain significant ALT activity and intracellular enzymes that can cause falsely elevated results. Serum samples are stable at 2–8°C for up to 7 days, and at –20°C or below for longer storage, although repeated freeze-thaw cycles should be avoided.

Plasma

Plasma collected with heparin or EDTA anticoagulants is generally acceptable for ALT testing. Anticoagulants such as sodium citrate or potassium oxalate may interfere with the enzymatic reaction or dilute the sample and should be validated before use. Plasma should be separated from cells promptly after centrifugation to prevent leakage of enzymes from blood cells.

Sample Volume and Preparation

Most automated assays require only a small sample volume, typically 10–25 microliters per test. Samples should be free from visible lipemia, hemolysis, and icterus where possible. If grossly lipemic samples must be tested, ultracentrifugation or sample blanking may be applied. Before analysis, samples and reagents should be brought to the operating temperature specified by the kit insert, commonly 37°C.

Testing Items

The core testing item of the ALT assay kit is the catalytic activity concentration of alanine aminotransferase, expressed in U/L (units per liter) or μkat/L. Additional parameters and performance specifications typically include:

• ALT activity concentration in serum or plasma (U/L)
• Reference interval, commonly approximately 9–50 U/L for males and 7–35 U/L for females, depending on the laboratory and population
• Linearity range, typically extending to 600–1000 U/L, beyond which samples require dilution and re-assay
• Analytical sensitivity, defined as the lowest detectable ALT activity distinguishable from zero
• Precision parameters, including within-run and between-run coefficients of variation
• Blank reagent absorbance limits to verify NADH stability at 340 nm

Testing Methods

IFCC Kinetic UV Method (Primary Method)

The internationally recommended procedure is the IFCC method without or with pyridoxal phosphate activation, performed at 37°C. The two-step coupled reaction proceeds as follows: in the first reaction, ALT catalyzes the conversion of L-alanine and alpha-ketoglutarate into pyruvate and L-glutamate; in the indicator reaction, LDH converts pyruvate and NADH into lactate and NAD+. The decrease in NADH absorbance at 340 nm (primary wavelength) is monitored continuously, usually with a bichromatic measurement using 405–700 nm as the secondary wavelength. During the pre-incubation phase, endogenous pyruvate in the sample is consumed by LDH, minimizing interference before the lag phase ends and the measurement interval begins.

Rate Calculation

ALT activity is calculated from the change in absorbance per minute using the following relationship: ALT activity (U/L) equals the change in absorbance per minute multiplied by a factor derived from the molar absorptivity of NADH, the light path length, and the sample-to-total-volume ratio. Automated analyzers compute this value automatically after excluding lag phases and non-linear segments, applying quality control checks for linearity of the reaction curve.

Colorimetric Endpoint Methods

Older methodologies, such as the Reitman-Frankel procedure, utilize 2,4-dinitrophenylhydrazine to derivatize the pyruvate formed, producing a colored hydrazone measured at 505–540 nm against a calibration curve. Although less precise than kinetic UV methods, colorimetric kits remain in use in laboratories with limited instrumentation or for teaching purposes.

Dry Chemistry and Point-of-Care Testing

Multi-layered dry chemistry slides incorporate the same enzymatic cascade in a solid-phase format, enabling ALT measurement on desk-top analyzers with minimal sample and reagent handling. These systems are valuable in emergency departments, blood collection stations, and resource-limited settings where rapid turnaround is required.

Microplate Adaptation for Research

For preclinical and pharmaceutical research, the ALT reaction can be scaled to 96-well microplates, allowing high-throughput screening of hepatoprotective compounds, drug-induced liver injury studies, and toxicological evaluation using serum from animal models. The kinetic reading at 340 nm on a microplate spectrophotometer follows the same enzymatic principle as the clinical assay.

Applications

ALT assay kits serve a broad spectrum of clinical, research, and public health applications, including the following areas:

• Clinical diagnosis of acute and chronic hepatitis, including viral hepatitis A, B, C, and E, where serum ALT elevation reflects hepatocellular inflammation
• Assessment and staging of non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, autoimmune hepatitis, and drug-induced liver injury
• Monitoring of liver function during long-term pharmacotherapy with potentially hepatotoxic drugs, such as statins, antituberculosis agents, anticonvulsants, and methotrexate
• Routine health examination panels and comprehensive metabolic profiles for early detection of asymptomatic liver dysfunction
• Blood donor screening to reduce the risk of transfusion-transmitted hepatitis
• Pre-operative and pre-admission evaluation of hepatic reserve
• Follow-up monitoring of patients with cirrhosis, liver fibrosis, and hepatocellular carcinoma during treatment
• Veterinary diagnostics for assessment of hepatic disorders in companion animals and livestock
• Pharmaceutical research, toxicology studies, and evaluation of hepatoprotective agents in experimental models

FAQ

What does an elevated ALT level indicate?

Elevated serum ALT most commonly indicates hepatocellular damage caused by viral hepatitis, fatty liver disease, alcohol abuse, drug toxicity, or ischemic liver injury. Mild elevations may also result from strenuous exercise, obesity, or recent muscle trauma. Clinical interpretation should always consider AST levels, the AST/ALT ratio (De Ritis ratio), bilirubin, alkaline phosphatase, GGT, and the patient history.

What is the difference between ALT and AST assays?

Both are transaminases detected with analogous coupled UV methods, but ALT is more liver-specific because it is concentrated in hepatocyte cytoplasm, whereas AST is also abundant in heart, skeletal muscle, kidney, and erythrocytes. Combined measurement and calculation of the AST/ALT ratio improve differential diagnosis of liver disorders.

What interferences can affect ALT assay results?

Major analytical interferences include hemolysis, which releases ALT and AST from red blood cells and adds LDH activity that consumes NADH; severe lipemia, which causes light scattering at 340 nm; and high bilirubin concentrations. Certain drugs and extremely high endogenous pyruvate levels may also bias results. Modern kits incorporate pre-incubation steps and sample blank correction to minimize these effects.

How should ALT reagent kits be stored and handled?

Unopened kits are typically stored at 2–8°C and protected from light to preserve NADH stability. Reconstituted or opened reagents remain stable for a defined period, commonly several weeks, when refrigerated and capped. Reagents should not be frozen unless specified by the manufacturer, and the absorbance of the working reagent at 340 nm should be verified against the minimum threshold stated in the package insert before use.

How is analytical quality controlled in ALT detection?

Laboratories should run at least two levels of quality control materials with known ALT activity at the beginning of each analytical session and at defined intervals thereafter. Participation in external quality assessment programs, regular calibration verification, linearity checks, and maintenance of analyzer parameters such as temperature, wavelength accuracy, and cuvette cleanliness are essential for reliable results.

Can the same kit be used for animal samples?

Yes, the enzymatic principle is species-independent, and the same ALT assay kits are widely applied to serum from mice, rats, dogs, cats, and livestock in research and veterinary practice. However, reference intervals differ significantly between species, and laboratories must establish or adopt species-specific decision limits.